Report Detail

Chemical & Material Global Finasteride API Market Research Report 2021

  • RnM4255446
  • |
  • 26 March, 2021
  • |
  • Global
  • |
  • 118 Pages
  • |
  • QYResearch
  • |
  • Chemical & Material

The research report includes specific segments by region (country), by manufacturers, by Type and by Application. Each type provides information about the production during the forecast period of 2016 to 2027. by Application segment also provides consumption during the forecast period of 2016 to 2027. Understanding the segments helps in identifying the importance of different factors that aid the market growth.

Segment by Type
Abrove 99% Purity
99% Purity
Under 99% Purity

Segment by Application
Pharmaceutical Industry
Research Organization
Others

By Company
AMRI
Mylan
Accord Pharmaceuticals
Sterling Spa
DEAFARMA
Gadea Grupo Farmacéutico, S.L.U.
Hetero
Dr.Reddys Laboratories
Pharmaffiliates
Cipla
Henan Topfond
Khonsu International
Aurobindo Pharma

Production by Region
North America
Europe
China
Japan

Consumption by Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Indonesia
Thailand
Malaysia
Philippines
Vietnam
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE


1 Finasteride API Market Overview

  • 1.1 Product Overview and Scope of Finasteride API
  • 1.2 Finasteride API Segment by Type
    • 1.2.1 Global Finasteride API Market Size Growth Rate Analysis by Type 2021 VS 2027
    • 1.2.2 Abrove 99% Purity
    • 1.2.3 99% Purity
    • 1.2.4 Under 99% Purity
  • 1.3 Finasteride API Segment by Application
    • 1.3.1 Global Finasteride API Consumption Comparison by Application: 2016 VS 2021 VS 2027
    • 1.3.2 Pharmaceutical Industry
    • 1.3.3 Research Organization
    • 1.3.4 Others
  • 1.4 Global Market Growth Prospects
    • 1.4.1 Global Finasteride API Revenue Estimates and Forecasts (2016-2027)
    • 1.4.2 Global Finasteride API Production Capacity Estimates and Forecasts (2016-2027)
    • 1.4.3 Global Finasteride API Production Estimates and Forecasts (2016-2027)
  • 1.5 Global Finasteride API Market by Region
    • 1.5.1 Global Finasteride API Market Size Estimates and Forecasts by Region: 2016 VS 2021 VS 2027
    • 1.5.2 North America Finasteride API Estimates and Forecasts (2016-2027)
    • 1.5.3 Europe Finasteride API Estimates and Forecasts (2016-2027)
    • 1.5.5 China Finasteride API Estimates and Forecasts (2016-2027)
    • 1.5.5 Japan Finasteride API Estimates and Forecasts (2016-2027)

2 Market Competition by Manufacturers

  • 2.1 Global Finasteride API Production Capacity Market Share by Manufacturers (2016-2021)
  • 2.2 Global Finasteride API Revenue Market Share by Manufacturers (2016-2021)
  • 2.3 Finasteride API Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
  • 2.4 Global Finasteride API Average Price by Manufacturers (2016-2021)
  • 2.5 Manufacturers Finasteride API Production Sites, Area Served, Product Types
  • 2.6 Finasteride API Market Competitive Situation and Trends
    • 2.6.1 Finasteride API Market Concentration Rate
    • 2.6.2 Global 5 and 10 Largest Finasteride API Players Market Share by Revenue
    • 2.6.3 Mergers & Acquisitions, Expansion

3 Production and Capacity by Region

  • 3.1 Global Production Capacity of Finasteride API Market Share by Region (2016-2021)
  • 3.2 Global Finasteride API Revenue Market Share by Region (2016-2021)
  • 3.3 Global Finasteride API Production, Revenue, Price and Gross Margin (2016-2021)
  • 3.4 North America Finasteride API Production
    • 3.4.1 North America Finasteride API Production Growth Rate (2016-2021)
    • 3.4.2 North America Finasteride API Production Capacity, Revenue, Price and Gross Margin (2016-2021)
  • 3.5 Europe Finasteride API Production
    • 3.5.1 Europe Finasteride API Production Growth Rate (2016-2021)
    • 3.5.2 Europe Finasteride API Production Capacity, Revenue, Price and Gross Margin (2016-2021)
  • 3.6 China Finasteride API Production
    • 3.6.1 China Finasteride API Production Growth Rate (2016-2021)
    • 3.6.2 China Finasteride API Production Capacity, Revenue, Price and Gross Margin (2016-2021)
  • 3.7 Japan Finasteride API Production
    • 3.7.1 Japan Finasteride API Production Growth Rate (2016-2021)
    • 3.7.2 Japan Finasteride API Production Capacity, Revenue, Price and Gross Margin (2016-2021)

4 Global Finasteride API Consumption by Region

  • 4.1 Global Finasteride API Consumption by Region
    • 4.1.1 Global Finasteride API Consumption by Region
    • 4.1.2 Global Finasteride API Consumption Market Share by Region
  • 4.2 North America
    • 4.2.1 North America Finasteride API Consumption by Country
    • 4.2.2 U.S.
    • 4.2.3 Canada
  • 4.3 Europe
    • 4.3.1 Europe Finasteride API Consumption by Country
    • 4.3.2 Germany
    • 4.3.3 France
    • 4.3.4 U.K.
    • 4.3.5 Italy
    • 4.3.6 Russia
  • 4.4 Asia Pacific
    • 4.4.1 Asia Pacific Finasteride API Consumption by Region
    • 4.4.2 China
    • 4.4.3 Japan
    • 4.4.4 South Korea
    • 4.4.5 Taiwan
    • 4.4.6 Southeast Asia
    • 4.4.7 India
    • 4.4.8 Australia
  • 4.5 Latin America
    • 4.5.1 Latin America Finasteride API Consumption by Country
    • 4.5.2 Mexico
    • 4.5.3 Brazil

5 Production, Revenue, Price Trend by Type

  • 5.1 Global Finasteride API Production Market Share by Type (2016-2021)
  • 5.2 Global Finasteride API Revenue Market Share by Type (2016-2021)
  • 5.3 Global Finasteride API Price by Type (2016-2021)

6 Consumption Analysis by Application

  • 6.1 Global Finasteride API Consumption Market Share by Application (2016-2021)
  • 6.2 Global Finasteride API Consumption Growth Rate by Application (2016-2021)

7 Key Companies Profiled

  • 7.1 AMRI
    • 7.1.1 AMRI Finasteride API Corporation Information
    • 7.1.2 AMRI Finasteride API Product Portfolio
    • 7.1.3 AMRI Finasteride API Production Capacity, Revenue, Price and Gross Margin (2016-2021)
    • 7.1.4 AMRI Main Business and Markets Served
    • 7.1.5 AMRI Recent Developments/Updates
  • 7.2 Mylan
    • 7.2.1 Mylan Finasteride API Corporation Information
    • 7.2.2 Mylan Finasteride API Product Portfolio
    • 7.2.3 Mylan Finasteride API Production Capacity, Revenue, Price and Gross Margin (2016-2021)
    • 7.2.4 Mylan Main Business and Markets Served
    • 7.2.5 Mylan Recent Developments/Updates
  • 7.3 Accord Pharmaceuticals
    • 7.3.1 Accord Pharmaceuticals Finasteride API Corporation Information
    • 7.3.2 Accord Pharmaceuticals Finasteride API Product Portfolio
    • 7.3.3 Accord Pharmaceuticals Finasteride API Production Capacity, Revenue, Price and Gross Margin (2016-2021)
    • 7.3.4 Accord Pharmaceuticals Main Business and Markets Served
    • 7.3.5 Accord Pharmaceuticals Recent Developments/Updates
  • 7.4 Sterling Spa
    • 7.4.1 Sterling Spa Finasteride API Corporation Information
    • 7.4.2 Sterling Spa Finasteride API Product Portfolio
    • 7.4.3 Sterling Spa Finasteride API Production Capacity, Revenue, Price and Gross Margin (2016-2021)
    • 7.4.4 Sterling Spa Main Business and Markets Served
    • 7.4.5 Sterling Spa Recent Developments/Updates
  • 7.5 DEAFARMA
    • 7.5.1 DEAFARMA Finasteride API Corporation Information
    • 7.5.2 DEAFARMA Finasteride API Product Portfolio
    • 7.5.3 DEAFARMA Finasteride API Production Capacity, Revenue, Price and Gross Margin (2016-2021)
    • 7.5.4 DEAFARMA Main Business and Markets Served
    • 7.5.5 DEAFARMA Recent Developments/Updates
  • 7.6 Gadea Grupo Farmacéutico, S.L.U.
    • 7.6.1 Gadea Grupo Farmacéutico, S.L.U. Finasteride API Corporation Information
    • 7.6.2 Gadea Grupo Farmacéutico, S.L.U. Finasteride API Product Portfolio
    • 7.6.3 Gadea Grupo Farmacéutico, S.L.U. Finasteride API Production Capacity, Revenue, Price and Gross Margin (2016-2021)
    • 7.6.4 Gadea Grupo Farmacéutico, S.L.U. Main Business and Markets Served
    • 7.6.5 Gadea Grupo Farmacéutico, S.L.U. Recent Developments/Updates
  • 7.7 Hetero
    • 7.7.1 Hetero Finasteride API Corporation Information
    • 7.7.2 Hetero Finasteride API Product Portfolio
    • 7.7.3 Hetero Finasteride API Production Capacity, Revenue, Price and Gross Margin (2016-2021)
    • 7.7.4 Hetero Main Business and Markets Served
    • 7.7.5 Hetero Recent Developments/Updates
  • 7.8 Dr.Reddys Laboratories
    • 7.8.1 Dr.Reddys Laboratories Finasteride API Corporation Information
    • 7.8.2 Dr.Reddys Laboratories Finasteride API Product Portfolio
    • 7.8.3 Dr.Reddys Laboratories Finasteride API Production Capacity, Revenue, Price and Gross Margin (2016-2021)
    • 7.8.4 Dr.Reddys Laboratories Main Business and Markets Served
    • 7.7.5 Dr.Reddys Laboratories Recent Developments/Updates
  • 7.9 Pharmaffiliates
    • 7.9.1 Pharmaffiliates Finasteride API Corporation Information
    • 7.9.2 Pharmaffiliates Finasteride API Product Portfolio
    • 7.9.3 Pharmaffiliates Finasteride API Production Capacity, Revenue, Price and Gross Margin (2016-2021)
    • 7.9.4 Pharmaffiliates Main Business and Markets Served
    • 7.9.5 Pharmaffiliates Recent Developments/Updates
  • 7.10 Cipla
    • 7.10.1 Cipla Finasteride API Corporation Information
    • 7.10.2 Cipla Finasteride API Product Portfolio
    • 7.10.3 Cipla Finasteride API Production Capacity, Revenue, Price and Gross Margin (2016-2021)
    • 7.10.4 Cipla Main Business and Markets Served
    • 7.10.5 Cipla Recent Developments/Updates
  • 7.11 Henan Topfond
    • 7.11.1 Henan Topfond Finasteride API Corporation Information
    • 7.11.2 Henan Topfond Finasteride API Product Portfolio
    • 7.11.3 Henan Topfond Finasteride API Production Capacity, Revenue, Price and Gross Margin (2016-2021)
    • 7.11.4 Henan Topfond Main Business and Markets Served
    • 7.11.5 Henan Topfond Recent Developments/Updates
  • 7.12 Khonsu International
    • 7.12.1 Khonsu International Finasteride API Corporation Information
    • 7.12.2 Khonsu International Finasteride API Product Portfolio
    • 7.12.3 Khonsu International Finasteride API Production Capacity, Revenue, Price and Gross Margin (2016-2021)
    • 7.12.4 Khonsu International Main Business and Markets Served
    • 7.12.5 Khonsu International Recent Developments/Updates
  • 7.13 Aurobindo Pharma
    • 7.13.1 Aurobindo Pharma Finasteride API Corporation Information
    • 7.13.2 Aurobindo Pharma Finasteride API Product Portfolio
    • 7.13.3 Aurobindo Pharma Finasteride API Production Capacity, Revenue, Price and Gross Margin (2016-2021)
    • 7.13.4 Aurobindo Pharma Main Business and Markets Served
    • 7.13.5 Aurobindo Pharma Recent Developments/Updates

8 Finasteride API Manufacturing Cost Analysis

  • 8.1 Finasteride API Key Raw Materials Analysis
    • 8.1.1 Key Raw Materials
    • 8.1.2 Key Raw Materials Price Trend
    • 8.1.3 Key Suppliers of Raw Materials
  • 8.2 Proportion of Manufacturing Cost Structure
  • 8.3 Manufacturing Process Analysis of Finasteride API
  • 8.4 Finasteride API Industrial Chain Analysis

9 Marketing Channel, Distributors and Customers

  • 9.1 Marketing Channel
  • 9.2 Finasteride API Distributors List
  • 9.3 Finasteride API Customers

10 Market Dynamics

  • 10.1 Finasteride API Industry Trends
  • 10.2 Finasteride API Growth Drivers
  • 10.3 Finasteride API Market Challenges
  • 10.4 Finasteride API Market Restraints

11 Production and Supply Forecast

  • 11.1 Global Forecasted Production of Finasteride API by Region (2022-2027)
  • 11.2 North America Finasteride API Production, Revenue Forecast (2022-2027)
  • 11.3 Europe Finasteride API Production, Revenue Forecast (2022-2027)
  • 11.4 China Finasteride API Production, Revenue Forecast (2022-2027)
  • 11.5 Japan Finasteride API Production, Revenue Forecast (2022-2027)

12 Consumption and Demand Forecast

  • 12.1 Global Forecasted Demand Analysis of Finasteride API
  • 12.2 North America Forecasted Consumption of Finasteride API by Country
  • 12.3 Europe Market Forecasted Consumption of Finasteride API by Country
  • 12.4 Asia Pacific Market Forecasted Consumption of Finasteride API by Region
  • 12.5 Latin America Forecasted Consumption of Finasteride API by Country

13 Forecast by Type and by Application (2022-2027)

  • 13.1 Global Production, Revenue and Price Forecast by Type (2022-2027)
    • 13.1.1 Global Forecasted Production of Finasteride API by Type (2022-2027)
    • 13.1.2 Global Forecasted Revenue of Finasteride API by Type (2022-2027)
    • 13.1.3 Global Forecasted Price of Finasteride API by Type (2022-2027)
  • 13.2 Global Forecasted Consumption of Finasteride API by Application (2022-2027)

14 Research Finding and Conclusion

    15 Methodology and Data Source

    • 15.1 Methodology/Research Approach
      • 15.1.1 Research Programs/Design
      • 15.1.2 Market Size Estimation
      • 15.1.3 Market Breakdown and Data Triangulation
    • 15.2 Data Source
      • 15.2.1 Secondary Sources
      • 15.2.2 Primary Sources
    • 15.3 Author List

    Summary:
    Get latest Market Research Reports on Finasteride API. Industry analysis & Market Report on Finasteride API is a syndicated market report, published as Global Finasteride API Market Research Report 2021. It is complete Research Study and Industry Analysis of Finasteride API market, to understand, Market Demand, Growth, trends analysis and Factor Influencing market.

    Last updated on

    REPORT YOU MIGHT BE INTERESTED

    Purchase this Report

    $2,900.00
    $4,350.00
    $5,800.00
    2,253.30
    3,379.95
    4,506.60
    2,720.20
    4,080.30
    5,440.40
    445,440.00
    668,160.00
    890,880.00
    244,847.00
    367,270.50
    489,694.00
    Credit card Logo

    Related Reports


    Reason to Buy

    Request for Sample of this report